| Literature DB >> 35846542 |
Manish Raturi1, Kunal Das2, Yashaswi Dhiman1.
Abstract
Entities:
Year: 2022 PMID: 35846542 PMCID: PMC9282703 DOI: 10.4103/ijstd.ijstd_122_20
Source DB: PubMed Journal: Indian J Sex Transm Dis AIDS ISSN: 2589-0557
Proposed modification in the specific high-risk behavior/s in the present blood donor selection criteria
| Specific conditions and deferral | Modifications in the guidelines as a modality for meeting blood requirements in the current COVID-19 pandemic | Our proposed modifications in the deferral criteria | Scientific rationale |
|---|---|---|---|
| IBDG | None | No deferral. Donation may be accepted based on detailed assessment and screening. The final discretion to defer lies with the in-charge of the BTC | Literature supports the same safety profile as heterosexuals for the blood components collected from transgender and MSM in monogamous relationships or those identified in low=risk criteria |
| U.S. FDA guidelines: | For MSM, the recommended deferral period is changed from 12 months to 3 months | No deferral. Donation may be accepted based on detailed assessment and screening. The final discretion to defer lies with the in-charge of the BTC | Literature supports the same safety profile as heterosexuals for the blood components collected from transgender and MSM in monogamous relationships or those identified in low-risk criteria |
IBDG=Indian blood donation guidelines; FDA=Food and Drug Administration; BTC=Blood transfusion centers; MSM=Men who have sex with men